GM
Gabriel S Morris
CFO, PresidentDirector

Gabriel S Morris insider trades: Immix Biopharma (IMMX) stock purchases

CFO, President, Immix Biopharma Last trade Dec 10, 2025 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$5K
Bought, last 12 months
1 buy
8
Open-market trades
since 2021
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gabriel reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 10, 2025IMMX↑ Buy$5K
Sep 16, 2025IMMX↑ Buy$5K
Jun 18, 2025IMMX↑ Buy$5K
Jun 7, 2024IMMX↑ Buy$5K
Jun 4, 2024IMMX↑ Buy$6K
May 14, 2024IMMX↑ Buy$10K
Nov 14, 2022IMMX↑ Buy$5K
Dec 20, 2021IMMX↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IMMX insiders

Open-market trades in the last 12 months

About Gabriel S Morris's insider trades

Gabriel S Morris is CFO, President at Immix Biopharma (IMMX). Since Dec 20, 2021, Gabriel has reported 8 open-market purchases worth $51K and no sales on SEC Form 4. In the last 12 months: 1 buy ($5K).

Their filings also include grants and awards (6 filings), option exercises (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.